These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21453386)

  • 21. Hedgehog signaling sensitizes glioma stem cells to endogenous nano-irradiation.
    Morgenroth A; Vogg AT; Ermert K; Zlatopolskiy B; Mottaghy FM
    Oncotarget; 2014 Jul; 5(14):5483-93. PubMed ID: 24978848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
    Fu J; Yang QY; Sai K; Chen FR; Pang JC; Ng HK; Kwan AL; Chen ZP
    Neuro Oncol; 2013 Oct; 15(10):1353-65. PubMed ID: 23877317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells.
    Zhang XP; Zheng G; Zou L; Liu HL; Hou LH; Zhou P; Yin DD; Zheng QJ; Liang L; Zhang SZ; Feng L; Yao LB; Yang AG; Han H; Chen JY
    Mol Cell Biochem; 2008 Jan; 307(1-2):101-8. PubMed ID: 17849174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal control of hematopoietic stem cell fate: Wnt, Notch, and Hedgehog as the usual suspects.
    Campbell C; Risueno RM; Salati S; Guezguez B; Bhatia M
    Curr Opin Hematol; 2008 Jul; 15(4):319-25. PubMed ID: 18536569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.
    Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG
    Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways.
    Li Z; Wang H; Eyler CE; Hjelmeland AB; Rich JN
    J Biol Chem; 2009 Jun; 284(25):16705-16709. PubMed ID: 19286664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor Cells.
    Shen Y; Chen H; Zhang J; Chen Y; Wang M; Ma J; Hong L; Liu N; Fan Q; Lu X; Tian Y; Wang A; Dong J; Lan Q; Huang Q
    PLoS One; 2015; 10(11):e0142594. PubMed ID: 26599017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hedgehog signaling in the pathogenesis of neuro-oncology diseases].
    Cherepanov SA; Baklaushev VP; Gabashvili AN; Shepeleva II; Chekhonin VP
    Biomed Khim; 2015; 61(3):332-42. PubMed ID: 26215410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma.
    Parmigiani E; Taylor V; Giachino C
    Cells; 2020 Oct; 9(10):. PubMed ID: 33076453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel roles for Notch, Wnt and Hedgehog in hematopoesis derived from human pluripotent stem cells.
    Cerdan C; Bhatia M
    Int J Dev Biol; 2010; 54(6-7):955-63. PubMed ID: 20336604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in glioma-associated oncogene (GLI) inhibitors for cancer therapy.
    Zhang M; Gao L; Ye Y; Li X
    Invest New Drugs; 2022 Apr; 40(2):370-388. PubMed ID: 34837604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells.
    Santini R; Pietrobono S; Pandolfi S; Montagnani V; D'Amico M; Penachioni JY; Vinci MC; Borgognoni L; Stecca B
    Oncogene; 2014 Sep; 33(38):4697-708. PubMed ID: 24681955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
    Mimeault M; Batra SK
    Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling.
    Chen Y; Wang Z; Dai X; Fei X; Shen Y; Zhang M; Wang A; Li X; Wang Z; Huang Q; Dong J
    Cancer Lett; 2015 Sep; 365(2):174-81. PubMed ID: 26049020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclopamine sensitizes glioblastoma cells to temozolomide treatment through Sonic hedgehog pathway.
    Carballo GB; Matias D; Ribeiro JH; Pessoa LS; Arrais-Neto AM; Spohr TCLSE
    Life Sci; 2020 Sep; 257():118027. PubMed ID: 32622951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network.
    Fareh M; Turchi L; Virolle V; Debruyne D; Almairac F; de-la-Forest Divonne S; Paquis P; Preynat-Seauve O; Krause KH; Chneiweiss H; Virolle T
    Cell Death Differ; 2012 Feb; 19(2):232-44. PubMed ID: 21720384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.
    Bar EE; Chaudhry A; Lin A; Fan X; Schreck K; Matsui W; Piccirillo S; Vescovi AL; DiMeco F; Olivi A; Eberhart CG
    Stem Cells; 2007 Oct; 25(10):2524-33. PubMed ID: 17628016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The functional role of Notch signaling in human gliomas.
    Stockhausen MT; Kristoffersen K; Poulsen HS
    Neuro Oncol; 2010 Feb; 12(2):199-211. PubMed ID: 20150387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOX3 can promote the malignant behavior of glioblastoma cells.
    Marjanovic Vicentic J; Drakulic D; Garcia I; Vukovic V; Aldaz P; Puskas N; Nikolic I; Tasic G; Raicevic S; Garros-Regulez L; Sampron N; Atkinson MJ; Anastasov N; Matheu A; Stevanovic M
    Cell Oncol (Dordr); 2019 Feb; 42(1):41-54. PubMed ID: 30209685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.